Inogen Inc. (Nasdaq: INGN), a provider of home respiratory care products, announced the appointment of Eric Pauls as vice president of sales for North America, effective this month.
Pauls previously served as chief customer officer at RQM+.
“As we advance towards the introduction of Simeox to the U.S. market, Eric’s experience with the respiratory business will help us facilitate a strong and effective rollout,” Gregoire Ramade, chief commercial officer for Inogen, said in a press release.
The home medical equipment (HME) manufacturer has made additional executive appointments in 2024.
In March, Inogen hired Michael Bourque to serve as the company’s chief financial officer. And in July, the California-based company announced the appointment of Kevin P. Smith as general counsel and executive vice president of business development.
Inogen is an international medical technology company specializing in respiratory products for home use. In August, Inogen reported a 6.1% increase in Q2 2024 revenue, reaching $88.8 million, driven by higher demand and new customers, particularly in international and domestic business-to-business (B2B) sales.
During the company’s Q2 earnings call, CEO Kevin R. Smith said he anticipates 3% to 5% growth for 2024, projecting full-year revenue between $325 million and $330 million, and that the company’s strategic focus includes innovation in personal oxygen concentrators and expansion in B2B channels.
